The incidence of methicillin-resistant Staphylococcus aureus (MRSA) is increasing, both in Canadian hospitals and worldwide, and is frequently covered in the media. As a result, pharmacists may get questions about MRSA, or encounter patients who are “MRSA-positive.” This letter will address a number of points regarding MRSA.
Get full access to this article
View all access options for this article.
References
1.
LowyFD. Staphylococcus aureus infections. N Engl J Med1998;339:520–32.
2.
SimorAE. Containing methicillin-resistant S. aureusPostgrad Med2001;110:43–8.
3.
ConlyJMJohnstonBL. The emergence of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in Canada. Can J Infect Dis 2003;14:249–51.
4.
SimorAELoebMThe management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper. Can J Infect Dis2004;15:39–48.
5.
McEvoyGK, ed. AHFS drug information 2004. Bethesda, MD: ASHP2004:3320–3.
